Literature DB >> 28591480

Laser interstitial thermal therapy: A first line treatment for seizures due to hypothalamic hamartoma?

Victor X Du1, Shashank V Gandhi1, Harold L Rekate1, Ashesh D Mehta1.   

Abstract

Successful treatment of hypothalamic hamartoma (HH) can result in the resolution of its sequelae including epilepsy and rage attacks. Risks and morbidity of open surgical management of this lesion have motivated the development of laser interstitial thermal therapy (LITT) as a less invasive treatment approach to the disease. Although overall morbidity and risk would appear to be lower, complications related to LITT therapy have been reported, and the longer-term follow-up that is now possible after initial experience helps address the question of whether LITT provides equivalent efficacy compared to other treatment options. We conducted a retrospective analysis of clinical outcomes in eight patients undergoing LITT for HH at our center using the Visualase/Medtronic device. Five patients had refractory epilepsy, one had rage attacks, and two had both. We also compared the published seizure-free outcomes over time and the complication rates for different interventional approaches to the treatment of epilepsy due to HH including open craniotomy, neuroendoscopic, radiosurgical, and radiofrequency approaches. With a mean follow-up of 19.1 months in our series of eight patients, six of seven epilepsy patients achieved seizure freedom, whereas the one patient with rage attacks only did not have improvement of his symptoms. A length of hospital stay of 2.6 days reflects low morbidity and rapid postoperative recuperation with LITT. Considering other reported series and case reports, the overall published seizure freedom rate of 21 of 25 patients is superior to published outcomes of HH cases treated by stereotactic radiosurgery (SRS), craniotomy, or neuroendoscopy, and comparable to radiofrequency ablation. The cumulative experience of our center with other published series supports relatively lower operative morbidity than more invasive approaches and efficacy that is as good or better than open craniotomy procedures and SRS. Although morbidity appears to be lower than other open approaches, complications related to LITT and their avoidance should be considered carefully. Wiley Periodicals, Inc.
© 2017 International League Against Epilepsy.

Entities:  

Keywords:  Gelastic epilepsy; Hypothalamic hamartoma; Laser interstitial thermal therapy; Stereotactic neurosurgery; Surgery for epilepsy

Mesh:

Year:  2017        PMID: 28591480     DOI: 10.1111/epi.13751

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Computational analysis of linear energy modulation for laser thermal coagulation.

Authors:  Van Nam Tran; Van Gia Truong; Seok Jeong; Hyun Wook Kang
Journal:  Biomed Opt Express       Date:  2018-05-09       Impact factor: 3.732

Review 2.  Surgical treatment of hypothalamic hamartomas.

Authors:  Pierre Bourdillon; S Ferrand-Sorbet; C Apra; M Chipaux; E Raffo; S Rosenberg; C Bulteau; N Dorison; O Bekaert; V Dinkelacker; C Le Guérinel; M Fohlen; G Dorfmüller
Journal:  Neurosurg Rev       Date:  2020-04-21       Impact factor: 3.042

Review 3.  Laser Interstitial Thermal Therapy for Cavernous Malformations: A Systematic Review.

Authors:  Omid Yousefi; Mohammadmahdi Sabahi; James Malcolm; Badih Adada; Hamid Borghei-Razavi
Journal:  Front Surg       Date:  2022-05-13

4.  Hypothalamic hamartomas in adulthood: Clinical spectrum and treatment outcome-A unicenter experience.

Authors:  Estefanía Conde Blanco; Carla Anciones Martín; Isabel Manzanares; Francisco Gil López; Pedro Roldán; Antonio Donaire; Jordi Rumiá; Mar Carreño
Journal:  Brain Behav       Date:  2019-10-02       Impact factor: 2.708

5.  Image-guided LINAC radiosurgery in hypothalamic hamartomas.

Authors:  Pantaleo Romanelli; Francesco Tuniz; Sara Fabbro; Giancarlo Beltramo; Alfredo Conti
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

6.  CyberKnife® Radiosurgery as First-line Treatment for Catastrophic Epilepsy Caused by Hypothalamic Hamartoma.

Authors:  Pantaleo Romanelli
Journal:  Cureus       Date:  2018-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.